Literature DB >> 28941521

The Use of the Woodchuck as an Animal Model for Evaluation of Transarterial Embolization.

Luke R Wilkins1, James R Stone2, Jaime Mata2, Alisha Hawrylack2, Ewa Kubicka3, David L Brautigan3.   

Abstract

There are many shortcomings of current animal models as surrogates of hepatocellular carcinoma that handicap preclinical testing of embolization agents. The present study explores the feasibility of using the woodchuck (Marmota monax) as an animal model for the testing of novel embolization agents. Four woodchucks underwent magnetic resonance imaging, angiography, and left lobar hepatic artery particle embolization. Percutaneous access, arteriography, and lobar embolization were successful in all animals, with angiographic stasis obtained in the target vessel with minimal reflux of embolic material. These results support the feasibility of the woodchuck as an animal model for preclinical testing of embolization agents.
Copyright © 2017 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28941521     DOI: 10.1016/j.jvir.2017.04.005

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  9 in total

Review 1.  Combined locoregional-immunotherapy for liver cancer.

Authors:  Tim F Greten; Michal Mauda-Havakuk; Bernd Heinrich; Firouzeh Korangy; Bradford J Wood
Journal:  J Hepatol       Date:  2019-02-07       Impact factor: 25.083

2.  Transarterial Chemoembolization in a Woodchuck Model of Hepatocellular Carcinoma.

Authors:  William F Pritchard; David L Woods; Juan A Esparza-Trujillo; Matthew F Starost; Michal Mauda-Havakuk; Andrew S Mikhail; Ivane Bakhutashvili; Shelby Leonard; Elizabeth C Jones; Venkatesh Krishnasamy; John W Karanian; Bradford J Wood
Journal:  J Vasc Interv Radiol       Date:  2020-02-24       Impact factor: 3.464

3.  Woodchuck Hepatic Anatomy and Vascular Alterations Due to Hepatocellular Carcinoma with Angiographic Atlas of the Abdomen and Pelvis.

Authors:  Michal Mauda-Havakuk; Michael T Kassin; Andrew S Mikhail; Juan A Esparza-Trujillo; Ivane Bakhutashvili; David L Woods; Paul G Wakim; Matthew F Starost; John W Karanian; Bradford J Wood; William F Pritchard
Journal:  J Vasc Interv Radiol       Date:  2021-11-17       Impact factor: 3.464

Review 4.  Animal Models of Hepatocellular Carcinoma for Local-Regional Intraarterial Therapies.

Authors:  Vishnu M Chandra; Luke R Wilkins; David L Brautigan
Journal:  Radiol Imaging Cancer       Date:  2022-07

5.  A Translational Hepatic Artery Infusion (HAI) Model for Hepatocellular Carcinoma in Woodchucks.

Authors:  Minhyung Kim; Colin A Powers; Leslie I Curtin; Daniel T Fisher; Sandra Sexton; Katerina V Gurova; Joseph J Skitzki; Renuka V Iyer
Journal:  J Surg Res       Date:  2020-03-03       Impact factor: 2.192

6.  Evaluation of immune-modulating drugs for use in drug-eluting microsphere transarterial embolization.

Authors:  Andrew S Mikhail; Michal Mauda-Havakuk; Ayele H Negussie; Natalie Hong; Natalie M Hawken; Camella J Carlson; Joshua W Owen; Olga Franco-Mahecha; Paul G Wakim; Andrew L Lewis; William F Pritchard; John W Karanian; Bradford J Wood
Journal:  Int J Pharm       Date:  2022-01-20       Impact factor: 6.510

7.  Suitability of the woodchuck HCC as a preclinical model for evaluation of intra-arterial therapies.

Authors:  Alexander Y Kim; Joseph H Yacoub; David H Field; Byoung Uk Park; Bhaskar Kallakury; Kyle E Korolowicz; Stephan Menne
Journal:  Animal Model Exp Med       Date:  2020-02-09

Review 8.  Combining Chemistry and Engineering for Hepatocellular Carcinoma: Nano-Scale and Smaller Therapies.

Authors:  Danielle L Stolley; Anna Colleen Crouch; Aliçan Özkan; Erin H Seeley; Elizabeth M Whitley; Marissa Nichole Rylander; Erik N K Cressman
Journal:  Pharmaceutics       Date:  2020-12-20       Impact factor: 6.321

Review 9.  Current Challenges in Image-Guided Magnetic Hyperthermia Therapy for Liver Cancer.

Authors:  Anirudh Sharma; Erik Cressman; Anilchandra Attaluri; Dara L Kraitchman; Robert Ivkov
Journal:  Nanomaterials (Basel)       Date:  2022-08-12       Impact factor: 5.719

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.